

Nexentis stock surged on AI drug discovery news before falling after announcing a $2.9 million offering.
You can purchase shares of Nexentis Technologies (NASDAQ:NXTS) through any online brokerage.
Other companies in Nexentis Technologies’s space includes: Nutrien Ltd (NYSE:NTR), CF Industries Holdings Inc (NYSE:CF), Corteva Inc (NYSE:CTVA), The Mosaic Co (NYSE:MOS) and ICL Group Ltd (NYSE:ICL).
There is no analysis for Nexentis Technologies to provide a consensus price target.
The stock price for Nexentis Technologies (NASDAQ: NXTS) is $0.545 last updated November 4, 2026 at 9:14 AM EST.
There are no upcoming dividends for Nexentis Technologies.
Nexentis Technologies does not have any upcoming earnings scheduled.
There is no upcoming split for Nexentis Technologies.
Nexentis Technologies is in the Materials sector and Chemicals industry. They are listed on the NASDAQ.
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for...